What happens when you take simvastatin with niacin?
Simvastatin (Zocor, and the combination pill Vytorin) is a statin that lowers LDL cholesterol. Niacin is vitamin B3. In large amounts, usually 1 gram a day or more, niacin is also used to change blood fats, either as a prescription (such as Niaspan) or as a high-strength supplement. Simvastatin can injure muscle, and niacin at those amounts adds to that risk.
- Simvastatin can cause myopathy: muscle pain, tenderness or weakness with a rise in the muscle enzyme creatine kinase (CK).
- Adding niacin at cholesterol-lowering amounts raises the chance of muscle injury: in a large trial it was more common than with simvastatin plus placebo.
- In rare cases, muscle injury becomes rhabdomyolysis, where damaged muscle releases proteins that can harm the kidneys.
- The Zocor label lists lipid-modifying doses of niacin (1 gram a day or more) among the things that increase the risk of myopathy and rhabdomyolysis.
- The risk is higher in Chinese patients, and the label says the combination is not recommended for them.
Why is this important?
This is not a theoretical concern. It was measured in one of the largest trials of niacin ever run, and it was run with simvastatin itself.
In HPS2-THRIVE, adults with vascular disease took simvastatin (with or without ezetimibe) and were randomly assigned to extended-release niacin (combined with laropiprant, a drug to reduce flushing) or placebo. Definite myopathy was about 4 times more common with niacin, and muscle problems were much more common in participants in China than in Europe.
The same trial found no reduction in heart attacks, strokes or other major vascular events from adding niacin, so for most people taking simvastatin the extra muscle risk did not buy a heart benefit. That is why the Zocor label asks prescribers to weigh benefit against risk for non-Chinese patients and advises against the combination for Chinese patients.
What should you do?
The principle is simple: cholesterol-dose niacin is a medicine decision, not a supplement add-on, when you take simvastatin.
Before starting niacin: If you take simvastatin and are thinking about a high-strength niacin product for cholesterol, talk to your prescriber first. Tell them if you are of Chinese descent, because the label treats that as a higher-risk group.
Every day while on both: If your prescriber has decided the combination is right for you, take both exactly as prescribed and pay attention to your muscles, especially in the first weeks and after any dose increase of either medicine.
If symptoms appear: Contact your doctor promptly about unexplained muscle pain, tenderness or weakness, especially with fever, tiredness or dark urine. Do not stop or change simvastatin on your own; your doctor may check your CK level and decide what to change.
Which specific products are affected?
On the medication side, this applies to simvastatin in any form: Zocor, generic simvastatin tablets, simvastatin oral suspension, and Vytorin (ezetimibe and simvastatin).
On the niacin side, the warning is about niacin (nicotinic acid) taken at 1 gram a day or more. That includes prescription extended-release niacin (Niaspan and generics), immediate-release niacin, and high-strength over-the-counter niacin sold for cholesterol. The small amounts of niacin in a standard multivitamin or B-complex are far below that level. Niacinamide (nicotinamide), a different form of vitamin B3 found in many multivitamins and skin products, is not used to lower cholesterol and is not the form the label warning describes. Read the Supplement Facts label for the form and the amount per serving.
The science behind it
The strongest evidence comes from the HPS2-THRIVE trial. Before randomization, 42,424 patients with occlusive arterial disease were put on simvastatin (plus ezetimibe if needed); 25,673 who tolerated extended-release niacin were then randomized to niacin-laropiprant or placebo and followed for a median of 3.9 years. Definite myopathy occurred in 75 participants on niacin versus 17 on placebo (0.16 versus 0.04 percent a year, risk ratio 4.4), and 7 versus 5 cases were rhabdomyolysis. Any myopathy (definite or incipient) was far more common in China (0.66 percent a year on niacin versus 0.13 percent on placebo) than in Europe (0.07 versus 0.04 percent a year) (HPS2-THRIVE Collaborative Group, Eur Heart J 2013, PMID 23444397).
The main results showed that niacin-laropiprant did not significantly reduce major vascular events (13.2 versus 13.7 percent) and increased serious adverse events, including musculoskeletal ones (HPS2-THRIVE Collaborative Group, N Engl J Med 2014, PMID 25014686).
The Zocor prescribing information on DailyMed reports cases of myopathy and rhabdomyolysis with lipid-modifying doses of niacin and notes that, in that trial, the incidence of myopathy in Chinese patients taking simvastatin with extended-release niacin was 1.24 percent. What was not shown: the trial used niacin combined with laropiprant, and it did not test the small niacin amounts found in multivitamins.
Frequently Asked Questions
Is the niacin in my multivitamin a problem with simvastatin?
The label warning and the trial are about niacin at 1 gram a day or more. Multivitamins contain far less. If you are unsure about a product, show the label to your pharmacist.
Why would anyone take niacin with a statin?
Niacin lowers LDL and raises HDL cholesterol, so it was once added to statins. In HPS2-THRIVE, adding it to simvastatin did not reduce heart attacks or strokes and raised side effects, so it is now used far less.
Does flush-free or slow-release niacin avoid the problem?
Slow-release niacin does not: the trial used an extended-release form, and it still raised muscle problems. Products sold as flush-free were not tested in the trial. Ask your pharmacist what form of niacin a product contains and how much.
Why does being of Chinese descent matter?
In the trial, myopathy was much more common in participants in China. The Zocor label says the combination is not recommended in Chinese patients.
What muscle symptoms should I watch for?
Unexplained muscle pain, tenderness or weakness, especially with fever, feeling unwell or dark urine. Contact your doctor promptly rather than waiting.
Is niacinamide the same as niacin?
No. Niacinamide is another form of vitamin B3 that is not used to lower cholesterol and is not the form the label warning describes.
Key takeaways
- Niacin at cholesterol-lowering amounts (1 gram a day or more) raises the risk of muscle injury with simvastatin.
- In HPS2-THRIVE, adding extended-release niacin to simvastatin raised definite myopathy about 4-fold without reducing major vascular events.
- The Zocor label says the combination is not recommended in Chinese patients, whose risk is higher.
- Multivitamin amounts of niacin, and niacinamide, are not what the warning is about.
- Report new muscle pain, weakness or dark urine promptly, and never change simvastatin on your own.
